BCL-2 is an anti-apoptotic protein that was discovered by mapping a t(14;18) chromosomal translocation in B-cell lymphoma that results in BCL-2 overexpression [1], [2]. Here, BCL2 is linked to B-cell non-Hodgkin lymphoma.